A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

about

A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

Item

http://www.wikidata.org/entity/Q56979547

description

im Dezember 2011 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2011

@uk

name

A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

@en

A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

@nl

type

Item

label

A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

@en

A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

@nl

prefLabel

A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

@en

A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

@nl

P1476

A Novel Generalized 3D-QSAR Model of Camptothecin Analogs

@en

P2093

Magdalena Bacilieri

http://www.w3.org/2001/XMLSchema#string

Marco Fanton

http://www.w3.org/2001/XMLSchema#string

Serena Basili

http://www.w3.org/2001/XMLSchema#string

P2860

Nonlinear partial differential equations and applications: The mechanism of topoisomerase I poisoning by a camptothecin analog

Topoisomerase I inhibitors: camptothecins and beyond

Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: design of new Gly/NMDA receptor antagonists as a key study.

Autocorrelation of molecular electrostatic potential surface properties combined with partial least squares analysis as new strategy for the prediction of the activity of human A(3) adenosine receptor antagonists.

The application of a 3D-QSAR (autoMEP/PLS) approach as an efficient pharmacodynamic-driven filtering method for small-sized virtual library: application to a lead optimization of a human A3 adenosine receptor antagonist.

20-(S)-camptothecin analogues as DNA topoisomerase I inhibitors: a QSAR study.

Prediction of the aqueous solvation free energy of organic compounds by using autocorrelation of molecular electrostatic potential surface properties combined with response surface analysis.

Molecular modeling of new camptothecin analogues to circumvent ABCG2-mediated drug resistance in cancer.

Novel camptothecin derivatives as topoisomerase I inhibitors.

Structure-activity relationship study of 16 a-thiocamptothecins: an integrated in vitro and in silico approach.

P304

927-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MINF.201100060

http://www.w3.org/2001/XMLSchema#string

P433

11-12

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Moro

Silvia Paoletta

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27468148

http://www.w3.org/2001/XMLSchema#string